Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Reich (1999)
Use of high-dose olanzapine in refractory psychosis.The American journal of psychiatry, 156 4
G. Tollefson, C. Beasley, P. Tran, J. Street, J. Krueger, R. Tamura, Karin Graffeo, Martha Thieme (1997)
Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.The American journal of psychiatry, 154 4
R. Conley, D. Kelly (2001)
Management of treatment resistance in schizophreniaBiological Psychiatry, 50
G. Tollefson, M. Birkett, G. Kiesler, A. Wood (2001)
Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapineBiological Psychiatry, 49
S. Dursun, D. Gardner, D. Bird, Janet Flinn (1999)
Olanzapine for Patients with Treatment-Resistant Schizophrenia: A Naturalistic Case-Series Outcome StudyThe Canadian Journal of Psychiatry, 44
R. Conley, C. Tamminga, D. Kelly, C. Richardson (1999)
Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-responseBiological Psychiatry, 46
H. Meltzer, S. McGurk (1999)
The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.Schizophrenia bulletin, 25 2
R. Love (1996)
Novel versus Conventional Antipsychotic DrugsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 16
Evan DeRenzo, Robert Conley, R. Love (1998)
Assessment of capacity to give consent to research participation: state-of-the-art and beyond.Journal of health care law & policy, 1 1
A. Fanous, J. Lindenmayer (1999)
Schizophrenia and schizoaffective disorder treated with high doses of olanzapine.Journal of clinical psychopharmacology, 19 3
J. Tracy, C. Monaco, T. Giovannetti, G. Abraham, R. Josiassen (2001)
Anticholinergicity and cognitive processing in chronic schizophreniaBiological Psychology, 56
B. Bronson, J. Lindenmayer (2000)
Adverse effects of high-dose olanzapine in treatment-refractory schizophrenia.Journal of clinical psychopharmacology, 20 3
C. Beasley, G. Tollefson, P. Tran, W. Satterlee, T. Sanger, S. Hamilton (1996)
Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 14
L. Citrome, J. Volavka (2002)
Optimal Dosing of Atypical Antipsychotics in Adults: A Review of the Current EvidenceHarvard Review of Psychiatry, 10
C. Mountjoy, A. Baldacchino, J. Stubbs (1999)
British experience with high-dose olanzapine for treatment-refractory schizophrenia.The American journal of psychiatry, 156 1
R. Conley, D. Kelly, C. Richardson, C. Tamminga, W. Carpenter (2003)
The efficacy of high-dose olanzapine versus clozapine in treatment-resistant schizophrenia: a double-blind crossover study.Journal of clinical psychopharmacology, 23 6
D. Kelly, R. Conley, C. Tamminga (1999)
Differential olanzapine plasma concentrations by sex in a fixed-dose studySchizophrenia Research, 40
J. Gerlach (2002)
Improving Outcome in Schizophrenia: The Potential Importance of EPS and Neuroleptic DysphoriaAnnals of Clinical Psychiatry, 14
GD Tollefson, MA Birkett, GM Kiesler, AJ Wood (2001)
Lilly Resistant Schizophrenia Study Group. Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapineBiol Psychiatry, 49
C Beasley, G Tollefson, P Tran, W Satterlee, T Sanger, S Hamilton (1996)
Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trialNeuropsychopharmacology, 14
D. Charney (2004)
Update on Biological PsychiatryBiological Psychiatry, 56
J. Volavka, P. Czobor, B. Sheitman, J. Lindenmayer, L. Citrome, J. McEvoy, T. Cooper, M. Chakos, J. Lieberman (2002)
Clozapine, Olanzapine, Risperidone, and Haloperidol in the Treatment of Patients With Chronic Schizophrenia and Schizoaffective DisorderAmerican Journal of Psychiatry, 159
A. Alao, W. Armenta, J. Yolles (1999)
High-Dose Olanzapine Therapy in Schizophrenia, 33
B. Sheitman, J. Lindgren, J. Early, M. Sved (1997)
High-dose olanzapine for treatment-refractory schizophrenia.The American journal of psychiatry, 154 11
Patients with treatment-resistant schizophrenia pose a major challenge to caregivers since only clozapine is documented as having superior efficacy in this population. Although olanzapine is similar to clozapine in structure and receptor profile, it has not been proven to have superior efficacy for this patient group. Nonetheless, olanzapine is being increasingly used in higher doses as clinicians attempt to find a more effective and tolerable therapy for refractory patients. Furthermore, there are little data comparing olanzapine and clozapine in this population. Thirteen patients participated in a randomized double-blind 16-week crossover study of clozapine therapy (450 mg/day) compared to high doses of olanzapine (50 mg/day). No patients on olanzapine responded while 20% responded to clozapine treatment. Olanzapine patients tended to experience higher rates of anticholinergic effects such as dry mouth (80 vs. 20%) and blurry vision (40 vs. 0%). Clozapine-treated patients had higher rates of sialorrhea (80 vs. 10%), sweating (50 vs. 10%), dyspepsia (70 vs. 30%), and lethargy (90 vs. 60%). Neither treatment was associated with significant akathisia. Liver enzyme elevation and lipids were higher with clozapine treatment. Mean weight gain in the initial 8 weeks was 3.4 kg for olanzapine and 1.2 kg for clozapine. High doses of olanzapine during 8 weeks of treatment did not increase lipids and liver enzymes like clozapine did. Olanzapine at 50 mg/day may be associated with more anticholinergic effects and weight gain than clozapine.
Annals of Clinical Psychiatry – Springer Journals
Published: Oct 11, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.